Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2776)
All Articles published online
|
Nov 7, 2005 (publication date) through May 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yi J, Gong WD, Wang L, Ling R, Chen JH, Yun J. VP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication. World J Gastroenterol 2005; 11(41): 6429-6432 [PMID: 16425411 DOI: 10.3748/wjg.v11.i41.6429] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i41/6429.htm |
| Number | Citing Articles |
| 1 |
Shaopeng Chen, Sung-Kay Chiu. AP4 activates cell migration and EMT mediated by p53 in MDA-MB-231 breast carcinoma cells. Molecular and Cellular Biochemistry 2015; 407(1-2): 57 doi: 10.1007/s11010-015-2454-7
|
| 2 |
W.‐X. Liu, H.‐H. Zhu, W. Wu, J.‐L. He, Z. Chen. Inhibition effect produced by dominant negative mutant fusion protein PreS2‐TLM‐ScFv‐HBcDN on HBV replication in vitro. Journal of Viral Hepatitis 2012; 19(4): 295 doi: 10.1111/j.1365-2893.2011.01547.x
|
| 3 |
Andrés Muñoz‐Alarcón, Henrik Helmfors, Kristin Karlsson, Ülo Langel. Fusion Protein Technologies for Biopharmaceuticals. 2013; : 397 doi: 10.1002/9781118354599.ch26
|